Scg
Chemicals & Related Products · Singapore · 51-200 Employees
View Company Info for Free
Overview
Headquarters
138 Depot Road #04-02, Singapore, Centra...Website
www.scgcell.comRevenue
$30.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Scg
SCG is a leading biotechnology company focusing on the development of novel immunotherapies in infections and its associated cancers. The company targets the most common cancer-causing infections: helicobacter pylori, HPV, HBV and EBV, and develops a broad and unique pipeline of TCR-based cellular immunotherapy products against infections associated cancers. With the proprietary GianTCRTM novel TCR screening platform and AutocellTM fully closed and automatic cell therapy manufacturing system, the company covers the entire value chain, from new target research and discovery, manufacturing, and clinical development.Explore more
Scg Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scg your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Scg had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Scg has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Scg is spiking on competitors!
Scg, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Scg launches new products
Congratulate Masked Content for being promoted to Masked Content at Scg
Earning: See what the market has to say on Scg recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Scg has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Scg is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Scg is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Scg.
Scg Tech Stack
A closer look at the technologies used by Scg
See more technologies
Scg News & Media
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
SINGAPORE, July 7, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the...SCG Announces Late-Breaking Clinical Data of SCG101 in HBV-Related Hepatocellular Carcinoma Presented at EASL 2025
SINGAPORE, May 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from its Phase 1 trial evaluating SCG101, autologous HBV-specific TCR-T cell therapy, in patients with advanced HBV-related hepatocellular carcinoma (HCC). These data were presented at the European Association for the Study of the Liver (EASL) Congress 2025. The resulSCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore
SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Initiative (NATi) to advance ribonucleic acid (RNA)-based therapeutic manufacturing process development and clinical translation. The parties will work together to fast-track RNA based therapeutics commercialisation from concept to patient treatment. Collaborative projects include RNA-based cell and gene therapy and mRNA vaccine manufacturing proceSCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data from its Phase 1 trial of SCG101, a first-in-class...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scg
Sign Up For FreeTo access detailed company insights
SCG is a leading biotechnology company focusing on the development of novel immunotherapies in infections and its associated cancers. The company targets the most common cancer-causing infections: helicobacter pylori, HPV, HBV and EBV, and develops a broad and unique pipeline of TCR-based cellular immunotherapy products against infections associate... Read More
